Eric Pelfrene

Bacteriophage therapy: a regulatory perspective

Eric Pelfrene, Elsa Willebrand, Ana Cavaleiro Sanches et al. · Journal of Antimicrobial Chemotherapy · 2016 · 127 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

Antimicrobial multidrug resistance in the era of COVID-19: a forgotten plight?

Eric Pelfrene, Radu Botgros, Marco Cavaleri · Antimicrobial Resistance and Infection Control · 2021 · 111 citations · Full text

Veterinary Medicine, Infectious Disease Control, Infectious Diseases +15

The European Medicines Agency’s scientific opinion on oral fexinidazole for human African trypanosomiasis

Eric Pelfrene, Martin Harvey Allchurch, Nsengi Ntamabyaliro et al. · PLoS neglected tropical diseases · 2019 · 41 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +16

Improving Conduct and Feasibility of Clinical Trials to Evaluate Antibacterial Drugs to Treat Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia: Recommendations of the Clinical Trials Transformation Initiative Antibacterial Drug Development Project Team

Charles Knirsch, Demissie Alemayehu, Radu Botgros et al. · Clinical Infectious Diseases · 2016 · 23 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Accelerating clinical drug development for children with tuberculosis

Stephen R. Murray, Lindsay McKenna, Eric Pelfrene et al. · The International Journal of Tuberculosis and Lung Disease · 2015 · 12 citations

Medicine, Pediatrics, Pharmacology +17